PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
-0.86%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$272M
AUM Growth
+$272M
(-21%)
Cap. Flow
-$18.7M
Cap. Flow
% of AUM
-6.88%
Top 10 Holdings %
Top 10 Hldgs %
40.84%
Holding
92
New
12
Increased
38
Reduced
26
Closed
16
Top Buys
| 1 |
Waters Corp
WAT
|
$8.69M |
| 2 |
Elevance Health
ELV
|
$8.57M |
| 3 |
Ionis Pharmaceuticals
IONS
|
$6.45M |
| 4 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
$4.93M |
| 5 |
United Therapeutics
UTHR
|
$4.17M |
Top Sells
| 1 |
BioCryst Pharmaceuticals
BCRX
|
$7.76M |
| 2 |
AbbVie
ABBV
|
$7.41M |
| 3 |
Idexx Laboratories
IDXX
|
$5.14M |
| 4 |
Aclaris Therapeutics
ACRS
|
$5.07M |
| 5 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$4.87M |
Sector Composition
| 1 | Healthcare | 96.48% |
| 2 | Industrials | 1.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
United Therapeutics
UTHR
$13.8B
| $21.6M | 7.97% | 91,806 +17,699 | +24% | +$4.17M |
|
2
UnitedHealth
UNH
$281B
| $14.8M | 5.45% | 28,811 +3,484 | +14% | +$1.79M |
|
|
SGEN
3
DELISTED
Seagen Inc. Common Stock
SGEN
| $13.6M | 4.99% | 76,626 -9,470 | -11% | -$1.68M |
|
4
Danaher
DHR
$147B
| $9.75M | 3.59% | 38,466 +1,494 | +4% | +$379K |
|
5
Xenon Pharmaceuticals
XENE
$2.98B
| $8.96M | 3.3% | 294,559 -9,627 | -3% | -$293K |
|
|
6
Waters Corp
WAT
$18B
| $8.69M | 3.2% | +26,250 | New | +$8.69M |
|
7
IQVIA
IQV
$32.4B
| $8.62M | 3.17% | 39,701 -10,389 | -21% | -$2.25M |
|
|
8
Elevance Health
ELV
$71.8B
| $8.57M | 3.15% | +17,750 | New | +$8.57M |
|
9
Neurocrine Biosciences
NBIX
$13.8B
| $8.34M | 3.07% | 85,589 +22,355 | +35% | +$2.18M |
|
10
iRhythm Technologies
IRTC
$5.46B
| $7.99M | 2.94% | 74,001 -29,980 | -29% | -$3.24M |
|
|
CTLT
11
DELISTED
CATALENT, INC.
CTLT
| $7.26M | 2.67% | 67,618 -11,431 | -14% | -$1.23M |
|
|
CDMO
12
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $7.04M | 2.59% | 461,226 +53,768 | +13% | +$820K |
|
13
Altimmune
ALT
$338M
| $6.55M | 2.41% | 559,755 +250,169 | +81% | +$2.93M |
|
14
Legend Biotech
LEGN
$6.41B
| $6.48M | 2.39% | 117,807 -2,666 | -2% | -$147K |
|
|
15
Ionis Pharmaceuticals
IONS
$6.79B
| $6.45M | 2.38% | +174,300 | New | +$6.45M |
|
|
CTIC
16
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $6.28M | 2.31% | 1,051,047 +826,047 | +367% | +$4.93M |
|
17
Avantor
AVTR
$9.18B
| $5.36M | 1.97% | 172,269 +13,904 | +9% | +$432K |
|
18
CVS Health
CVS
$92.8B
| $4.96M | 1.83% | 53,547 -32,071 | -37% | -$2.97M |
|
19
Tenet Healthcare
THC
$16.3B
| $4.85M | 1.78% | 92,190 -46,995 | -34% | -$2.47M |
|
|
RCM
20
DELISTED
R1 RCM Inc. Common Stock
RCM
| $4.83M | 1.78% | 230,413 -112,510 | -33% | -$2.36M |
|
|
CNCE
21
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $4.73M | 1.74% | 1,124,072 +746,673 | +198% | +$3.14M |
|
22
Arcus Biosciences
RCUS
$1.13B
| $4.34M | 1.6% | 171,214 +3,893 | +2% | +$98.7K |
|
|
23
Aclaris Therapeutics
ACRS
$209M
| $4.26M | 1.57% | 304,843 -363,255 | -54% | -$5.07M |
|
24
Alphatec Holdings
ATEC
$2.35B
| $3.43M | 1.26% | 523,735 +71,941 | +16% | +$470K |
|
25
Cooper Companies
COO
$13.4B
| $3.29M | 1.21% | 10,500 -9,085 | -46% | -$2.84M |
|